Literature DB >> 2022963

A new mouse mutant with progressive motor neuronopathy.

H Schmalbruch1, H J Jensen, M Bjaerg, Z Kamieniecka, L Kurland.   

Abstract

A new autosomal-recessive mouse mutant with progressive motor neuronopathy (pmn) is described. Homozygotes develop paralysis of the hindlimbs during the third week of life. Soon thereafter the forelimbs also become weak, and all mice die six to seven weeks after birth. Heterozygotes are normal. Skeletal muscles show neurogenic atrophy without histological signs of reinnervation. Axonal degeneration apparently starts at the endplates and is prominent in the sciatic nerve and its branches and the phrenic nerve. Axonal sprouts are abundant. There is no evidence of demyelination, and unaffected nerve fibers are normally myelinated. Sensory axons are spared. Almost all distal motor axons have disappeared in four to five weeks after birth. Ventral nerve roots show a reduced diameter of the largest fibers but no fiber deficits. The ventral horn cells show slight chromatolysis. The corticospinal tract is normal, but in terminally ill animals the fasciculus gracilis, the rubrospinal tract and possibly also reticulospinal fibers degenerate. The brain is histologically normal. The disease manifests itself in a dying-back fashion in the distal portion of the motor neurons and may represent an animal model of hereditary motor neuron diseases in man.

Entities:  

Mesh:

Year:  1991        PMID: 2022963     DOI: 10.1097/00005072-199105000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

1.  Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21.

Authors:  K Grohmann; T F Wienker; K Saar; S Rudnik-Schöneborn; G Stoltenburg-Didinger; R Rossi; G Novelli; G Nürnberg; A Pfeufer; B Wirth; A Reis; K Zerres; C Hübner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice.

Authors:  M Sendtner; R Götz; B Holtmann; H Thoenen
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 3.  Axon pruning: an essential step underlying the developmental plasticity of neuronal connections.

Authors:  Lawrence K Low; Hwai-Jong Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

4.  Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease.

Authors:  Y Sagot; T Rossé; R Vejsada; D Perrelet; A C Kato
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

Review 5.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 6.  Neurotrophic factors and neurologic disease.

Authors:  D M Holtzman; W C Mobley
Journal:  West J Med       Date:  1994-09

7.  TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy.

Authors:  Antonella Sferra; Gilbert Baillat; Teresa Rizza; Sabina Barresi; Elisabetta Flex; Giorgio Tasca; Adele D'Amico; Emanuele Bellacchio; Andrea Ciolfi; Viviana Caputo; Serena Cecchetti; Annalaura Torella; Ginevra Zanni; Daria Diodato; Emanuela Piermarini; Marcello Niceta; Antonietta Coppola; Enrico Tedeschi; Diego Martinelli; Carlo Dionisi-Vici; Vincenzo Nigro; Bruno Dallapiccola; Claudia Compagnucci; Marco Tartaglia; Georg Haase; Enrico Bertini
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

Review 8.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

9.  Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology.

Authors:  Lyndsay M Murray; Derek Thomson; Annalijn Conklin; Thomas M Wishart; Thomas H Gillingwater
Journal:  J Anat       Date:  2008-12       Impact factor: 2.610

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.